companydata.dkcompanydata.dk

ZEMA Pharma Consulting ApS: Financial statements 2023

CVR: 42680427

Source: annual report 2023, Danish Business Authority

01/10/2022 – 30/09/2023

ZEMA Pharma Consulting ApS (CVR 42680427) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,472,110 and a net result of DKK 812,354 compared with DKK 789,558 the year before. That is an increase of 28.4% compared with the year before. Equity in the 2023 report amounted to DKK 852,912. The solvency ratio was 53.8%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,472,110
Profit/Loss
DKK 812,354
Equity
DKK 852,912
Total Assets
DKK 1,586,535
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-1.5M812K853K1
2022-1.1M790K830K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

About ZEMA Pharma Consulting ApS

ZEMA Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Dyssegård, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mads Torkild Hansen. The company is owned by Mads Torkild Hansen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 102,227 and a net result of DKK -216,744 compared with DKK -281,625 the year before. Equity in the 2025 report amounted to DKK 354,543.

Source: annual report 2025, Danish Business Authority

Other financial years